Australia markets closed

Prescient Therapeutics Limited (PTX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0630+0.0030 (+5.00%)
At close: 4:11PM AEST
Currency in AUD

Valuation measures

Market cap (intra-day) 524.84M
Enterprise value 315.6M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)16.17
Price/book (mrq)1.97
Enterprise value/revenue 310.16
Enterprise value/EBITDA 6-3.92

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 342.86%
S&P500 52-week change 316.78%
52-week high 30.1500
52-week low 30.0220
50-day moving average 30.0590
200-day moving average 30.0483

Share statistics

Avg vol (3-month) 32.83M
Avg vol (10-day) 33.97M
Shares outstanding 5394.26M
Float 329.45M
% held by insiders 115.27%
% held by institutions 19.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 302 Dec 2014

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2019
Most-recent quarter (mrq)31 Dec 2019

Profitability

Profit margin -253.86%
Operating margin (ttm)-259.25%

Management effectiveness

Return on assets (ttm)-22.75%
Return on equity (ttm)-37.67%

Income statement

Revenue (ttm)1.54M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-15.70%
Gross profit (ttm)1.65M
EBITDA -3.98M
Net income avi to common (ttm)-3.9M
Diluted EPS (ttm)-0.0120
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.24M
Total cash per share (mrq)0.02
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)15.64
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-2.5M
Levered free cash flow (ttm)-1.11M